Free Trial

IRIDEX (IRIX) Short Interest Ratio & Short Volume

$2.05
+0.06 (+3.02%)
(As of 07/26/2024 ET)

IRIDEX Short Interest Data

Current Short Interest
330,600 shares
Previous Short Interest
339,500 shares
Change Vs. Previous Month
-2.62%
Dollar Volume Sold Short
$700,872.00
Short Interest Ratio
10.5 Days to Cover
Last Record Date
July 15, 2024
Outstanding Shares
16,250,000 shares
Float Size
12,050,000 shares
Short Percent of Float
2.74%
Today's Trading Volume
48,187 shares
Average Trading Volume
32,625 shares
Today's Volume Vs. Average
148%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling IRIDEX ?

Sign up to receive the latest short interest report for IRIDEX and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IRIX Short Interest Over Time

IRIX Days to Cover Over Time

IRIX Percentage of Float Shorted Over Time

IRIDEX Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2024330,600 shares $700,872.00 -2.6%2.7%10.5 $2.12
6/30/2024339,500 shares $733,320.00 +6.9%2.8%10.7 $2.16
6/15/2024317,500 shares $666,750.00 +8.7%2.6%8.2 $2.10
5/31/2024292,200 shares $710,046.00 -8.1%2.4%7.4 $2.43
5/15/2024317,800 shares $842,170.00 +1.3%2.6%8 $2.65
4/30/2024313,600 shares $893,760.00 -5.2%2.6%9.1 $2.85
4/15/2024330,800 shares $1.05 million +3.5%2.7%9.6 $3.17
3/31/2024319,500 shares $952,110.00 +1.7%2.6%9 $2.98
3/15/2024314,300 shares $757,463.00 -0.3%2.6%10.8 $2.41
2/29/2024315,200 shares $847,888.00 -1.4%2.6%11.1 $2.69
2/15/2024319,500 shares $869,040.00 -2.1%2.6%8.3 $2.72
1/31/2024326,300 shares $920,166.00 -8.0%2.7%6.3 $2.82
1/15/2024354,600 shares $1.07 million +7.7%2.9%3.6 $3.02
12/31/2023329,400 shares $925,614.00 +1.8%2.7%3.1 $2.81
12/15/2023323,700 shares $864,279.00 -4.0%2.7%2.7 $2.67
11/30/2023337,000 shares $859,350.00 +5.6%2.8%2.6 $2.55
11/15/2023319,200 shares $647,976.00 +79.9%2.6%2.5 $2.03
10/31/2023177,400 shares $581,872.00 +43.3%1.5%1.4 $3.28
10/15/2023123,800 shares $371,400.00 +42.6%1.0%1.6 $3.00
9/30/202386,800 shares $220,472.00 -7.3%0.7%1.3 $2.54
9/15/202393,600 shares $189,072.00 +52.9%0.8%2.3 $2.02
8/31/202361,200 shares $101,592.00 +13.3%0.5%2.1 $1.66
8/15/202354,000 shares $81,540.00 +11.8%0.5%2.2 $1.51
7/31/202348,300 shares $98,532.00 -22.7%0.4%3.7 $2.04
7/15/202362,500 shares $125,000.00 -2.2%0.5%4.3 $2.00
6/30/202363,900 shares $138,663.00 +37.4%0.5%4.3 $2.17
6/15/202346,500 shares $93,930.00 -0.9%0.4%3 $2.02
5/31/202346,900 shares $100,835.00 -2.9%0.4%3 $2.15
5/15/202348,300 shares $108,675.00 No Change0.4%3.2 $2.25
10/31/202263,000 shares $141,750.00 -18.8%0.4%1.8 $2.25
10/15/202277,600 shares $187,016.00 -15.1%0.7%2.1 $2.41
9/30/202291,400 shares $220,274.00 +1.3%0.8%2.5 $2.41
9/15/202290,200 shares $222,794.00 +2.2%0.8%2.1 $2.47
8/31/202288,300 shares $229,580.00 +34.8%0.7%2 $2.60
8/15/202265,500 shares $217,460.00 -8.8%0.5%1.7 $3.32
7/31/202271,800 shares $216,118.00 +2.9%0.6%2 $3.01
7/15/202269,800 shares $183,574.00 +15.6%0.6%1.9 $2.63
6/30/202260,400 shares $155,228.00 +1.5%0.5%1.5 $2.57
6/15/202259,500 shares $162,435.00 -4.7%0.5%1.5 $2.73
5/31/202262,400 shares $186,576.00 -9.8%0.5%1.5 $2.99
This TSLA short trade is on a nine win hot streak (Ad)

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.
5/15/202269,200 shares $228,360.00 -0.7%0.5%1.6 $3.30
4/30/202269,700 shares $266,951.00 -14.3%0.5%1.7 $3.83
4/15/202281,300 shares $352,842.00 +18.5%0.6%2 $4.34
3/31/202268,600 shares $317,618.00 +2.2%N/A0 $4.63
3/15/202267,100 shares $275,110.00 -19.8%0.5%1.9 $4.10
2/28/202283,700 shares $373,302.00 -12.1%0.7%2.5 $4.46
2/15/202295,200 shares $479,808.00 -23.9%0.7%2.4 $5.04
1/31/2022125,100 shares $660,528.00 -25.2%1.0%2.6 $5.28
1/15/2022167,300 shares $933,534.00 +3.1%N/A3.2 $5.58
12/31/2021162,300 shares $991,653.00 -6.4%1.3%3 $6.11
12/15/2021173,300 shares $1.03 million -3.9%1.4%2.9 $5.92
11/30/2021180,400 shares $1.13 million +7.0%1.4%3 $6.25
11/15/2021168,600 shares $1.35 million +3.9%1.3%2.8 $8.00
10/29/2021162,300 shares $1.24 million +15.5%1.3%3 $7.67
10/15/2021140,500 shares $1.04 million +2.5%1.1%2.9 $7.41
9/30/2021137,100 shares $1.05 million -4.2%1.1%2.8 $7.66
9/15/2021143,100 shares $1.03 million -4.6%1.1%3 $7.20
8/31/2021150,000 shares $1.14 million -2.9%1.2%2.9 $7.57
8/13/2021154,400 shares $1.23 million +4.3%1.2%2.8 $7.98
7/30/2021148,000 shares $967,920.00 +5.9%1.2%2.7 $6.54
7/15/2021139,800 shares $894,720.00 +2.0%1.1%2 $6.40
6/30/2021137,000 shares $967,220.00 -12.9%1.1%1.9 $7.06
6/15/2021157,200 shares $1.20 million -42.7%1.2%1.9 $7.63
5/28/2021274,300 shares $2.16 million -7.0%2.2%2.9 $7.86
5/14/2021294,900 shares $2.13 million -7.1%2.3%2.3 $7.21
4/30/2021317,300 shares $2.77 million -14.4%2.6%1.9 $8.72
4/15/2021370,600 shares $2.75 million -0.9%3.1%2.1 $7.41
3/31/2021373,900 shares $2.62 million +10.5%3.2%0.9 $7.00
3/15/2021338,300 shares $2.57 million +95.9%2.8%0.6 $7.60
2/26/2021172,700 shares $1.04 million +13.3%1.4%0.3 $6.00
2/12/2021152,400 shares $786,384.00 -17.6%1.3%0.3 $5.16
1/29/2021184,900 shares $880,124.00 -73.5%1.6%0.4 $4.76
1/15/2021696,700 shares $3.85 million +69.6%5.9%1.5 $5.53
12/31/2020410,700 shares $1.16 million +106.9%3.5%1.1 $2.82
12/15/2020198,500 shares $341,420.00 +8.8%1.7%2.6 $1.72
11/30/2020182,500 shares $308,425.00 -12.3%1.5%3.1 $1.69
11/15/2020208,200 shares $370,596.00 +11.9%1.8%5 $1.78
10/30/2020186,100 shares $338,702.00 +3.6%1.6%8 $1.82
10/15/2020179,600 shares $359,200.00 -0.4%1.5%6.6 $2.00
9/30/2020180,400 shares $353,584.00 +4.3%1.5%6.2 $1.96
9/15/2020173,000 shares $339,253.00 +2.4%1.5%5.5 $1.96
8/31/2020169,000 shares $349,830.00 +0.8%1.4%5.5 $2.07
8/14/2020167,700 shares $397,449.00 +0.9%1.4%6.1 $2.37
7/31/2020166,200 shares $335,724.00 +2.9%1.4%5.3 $2.02
7/15/2020161,500 shares $323,000.00 -1.5%1.4%5.6 $2.00
6/30/2020164,000 shares $341,120.00 +1.9%1.4%5.9 $2.08
6/15/2020161,000 shares $333,270.00 +2.3%1.4%5.5 $2.07
5/29/2020157,400 shares $273,876.00 +48.4%1.3%4.7 $1.74
5/15/2020106,100 shares $159,150.00 +235.8%0.9%3.7 $1.50
4/30/202031,600 shares $55,300.00 +65.5%0.3%0.9 $1.75
This TSLA short trade is on a nine win hot streak (Ad)

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.
4/15/202019,100 shares $31,324.00 +33.6%0.2%0.5 $1.64
3/31/202014,300 shares $24,453.00 +123.4%0.1%0.2 $1.71
3/13/20206,400 shares $12,032.00 -73.4%0.1%0.3 $1.88
2/28/202024,100 shares $33,740.00 -1.6%0.2%0.4 $1.40
2/14/202024,500 shares $51,205.00 +109.4%0.2%0.4 $2.09
1/31/202011,700 shares $36,153.00 -85.2%0.1%0.2 $3.09
1/15/202078,800 shares $286,832.00 -12.0%0.7%1.1 $3.64
12/31/201989,500 shares $254,180.00 +5.7%0.8%1.4 $2.84

IRIX Short Interest - Frequently Asked Questions

What is IRIDEX's current short interest?

Short interest is the volume of IRIDEX shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 330,600 shares of IRIX short. 2.74% of IRIDEX's shares are currently sold short. Learn More on IRIDEX's current short interest.

What is a good short interest ratio for IRIDEX?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRIX shares currently have a short interest ratio of 10.0. Learn More on IRIDEX's short interest ratio.

What is a good short interest percentage for IRIDEX?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.74% of IRIDEX's floating shares are currently sold short.

Is IRIDEX's short interest increasing or decreasing?

IRIDEX saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 330,600 shares, a decline of 2.6% from the previous total of 339,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is IRIDEX's float size?

IRIDEX currently has issued a total of 16,250,000 shares. Some of IRIDEX's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IRIDEX currently has a public float of 12,050,000 shares.

How does IRIDEX's short interest compare to its competitors?

2.74% of IRIDEX's shares are currently sold short. Here is how the short interest of companies compare to IRIDEX: electroCore, Inc. (0.33%), Rockwell Medical, Inc. (2.01%), FONAR Co. (0.22%), Vivani Medical, Inc. (3.61%), Pro-Dex, Inc. (0.49%), SurgePays, Inc. (3.92%), SEP Acquisition Corp. (0.24%), Cytosorbents Co. (2.67%), Modular Medical, Inc. (0.62%), Envoy Medical, Inc. (0.34%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short IRIDEX stock?

Short selling IRIX is an investing strategy that aims to generate trading profit from IRIDEX as its price is falling. IRIX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against IRIDEX?

A short squeeze for IRIDEX occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRIX, which in turn drives the price of the stock up even further.

How often is IRIDEX's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRIX, twice per month. The most recent reporting period available is July, 15 2024.



This page (NASDAQ:IRIX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners